Citius Oncology (NASDAQ:CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals (NASDAQ:CTXR), has entered into a distribution services agreement with Cardinal Health (NYSE:CAH).
This agreement is designed to help provide access to LYMPHIR (denileukin diftitox-cxdl), an innovative immunotherapy FDA-approved for the treatment of adults
President Donald Trump delivered a politically charged speech Wednesday carried live in prime time on network television, seeking to pin the blame for...
SEBI’s move to unbundle statutory levies such as GST, STT and stamp duty from the total expense ratio (TER) of...
Nvidia has confirmed "Globes" report that it has chosen the Israel Land Authority (ILA) area in Kiryat Tivon to...
Asian stocks opened lower following US losses as global markets fell into a familiar, risk-off pattern with tech concerns weighing...
The founder of Tricolor Holdings led other top executives of the subprime auto lender on a seven-year campaign to defraud...
A new savings vehicle, dubbed “Trump accounts,” is designed to help the rising generation of American children build wealth into...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
